Although CASPR2 antibodies are considered low-risk antibodies for PNS and are associated with malignant thymoma (6), one case of PNS with CASPR2 antibodies and lymphoma has been reported (26). Here, CNTNAP2 is linked to paraneoplastic neurologic syndrome.